Human pyroglutamyl peptidases and their involvement in Alzheimer's disease
The N-terminally pyroglutamyl-modified β-amyloid (Aβ) peptides are found in abundance in the pathological Alzheimer disease (AD) brain deposits. Such modification not only increases the hydrophobic properties of a given molecule, but also plays a protecting role against proteolytic degradation. This...
Main Author: | Slonka, Justyna |
---|---|
Other Authors: | Littlechild, Jennifer |
Published: |
University of Exeter
2011
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.566219 |
Similar Items
-
Studies on pyroglutamyl carboxyl peptidase enzymes and cholinesterase inhibitors : implications for Alzheimer's disease
by: Connelly, Stephen
Published: (2006) -
Role of human cystatin C in Alzheimer's disease
by: Elshawaihde, Adham S. H.
Published: (2012) -
The extracellular matrix in Alzheimer's disease
by: Baig, Shabnam Mobeen
Published: (2006) -
The perceptions of cause and control in people with Alzheimer's disease
by: Matchwick, Claire
Published: (2011) -
Polyunsaturated fatty acid oxidation in Alzheimer’s disease
by: Smith, Simon
Published: (2011)